Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-07

FDA Approved: TAPENTADOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for tapentadol hydrochloride from Hikma Pharmaceuticals USA Inc., enabling a generic version of tapentadol for pain mana…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tapentadol hydrochloride (Tapentadol hydrochloride)

Snippet

SUPPL AP for TAPENTADOL (TAPENTADOL HYDROCHLORIDE)